Anonymous
Guest
Anonymous
Guest
Proxy fight looming at Conmed • 10:08 AM
• In a letter to shareholders, Conmed (CNMD +0.3%) COB Mark Tryniski and interim CEO Curt Hartman urge shareholders to vote against the three board nominees put forth by institutional investor Voce Capital Management LLC. The annual shareholders meeting is September 10, 2014.
• The officers maintain that they have implemented a plan to improve performance, including installing new board members and operating executives. They say their plan addresses every issue that Voce has raised. They assert that Voce does not have a comparable plant to improve the firm's prospects and that it only wants the company to be sold.
• In a letter to shareholders, Conmed (CNMD +0.3%) COB Mark Tryniski and interim CEO Curt Hartman urge shareholders to vote against the three board nominees put forth by institutional investor Voce Capital Management LLC. The annual shareholders meeting is September 10, 2014.
• The officers maintain that they have implemented a plan to improve performance, including installing new board members and operating executives. They say their plan addresses every issue that Voce has raised. They assert that Voce does not have a comparable plant to improve the firm's prospects and that it only wants the company to be sold.